|
Jul 24
|
The 3 Things That Matter for AbbVie Now
|
|
Jul 24
|
AbbVie Insiders Sell US$50m Of Stock, Possibly Signalling Caution
|
|
Jul 24
|
Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics
|
|
Jul 24
|
Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL
|
|
Jul 24
|
iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments
|
|
Jul 23
|
Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports
|
|
Jul 23
|
Accelerating innovation in early Alzheimer’s disease diagnosis
|
|
Jul 23
|
Atopic Dermatitis Market Forecast Report 2025-2034 | FDA Approval of Tralokinumab-Ldrm Stimulates Treatment Advances
|
|
Jul 22
|
AbbVie (ABBV) Outperforms Broader Market: What You Need to Know
|
|
Jul 22
|
Top Research Reports for NVIDIA, Amazon.com & Meta Platforms
|
|
Jul 22
|
How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?
|
|
Jul 22
|
BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project
|
|
Jul 21
|
This 12 Dividend Stock Portfolio Will Pay Your Bills – Every Week
|
|
Jul 21
|
Looking for Cheap Stocks? Healthcare Shares Haven’t Looked This Good in 30 Years.
|
|
Jul 21
|
Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025
|
|
Jul 20
|
Morgan Stanley Reiterates a Buy Rating on AbbVie (ABBV) With a $250 PT
|
|
Jul 19
|
All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year
|
|
Jul 19
|
Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector
|
|
Jul 17
|
AbbVie Inc. (NYSE:ABBV) is favoured by institutional owners who hold 75% of the company
|
|
Jul 16
|
AbbVie (ABBV) Surpasses Market Returns: Some Facts Worth Knowing
|